Colossal Biosciences has led the pack of de-extinction companies and just received a record-breaking $200 million in Series C funding from TWG Global for its high-profile projects. From initially reviving the woolly mammoth, dodo, and thylacine, they have shifted their gears to the most ambitious dream: bringing back dinosaurs into the world. Colossal will change the course of evolutionary history. With cutting-edge tools such as CRISPR-Cas9 and artificial womb technologies, not to mention synthetic biology tools, it appears to rewrite everything that had passed and was previously thought to remain so. There is a greater meaning behind species revival; Colossal can help researchers in the issues of human health, agriculture, and biodiversity preservation, aside from saving the dinosaurs, which are at present still strictly theoretical.